Dimopoulos MA, Kastritis E, Michalis E, Tsatalas C, Michael M, Pouli A, Kartasis Z, Delimpasi S, Gika D, Zomas A, et al. The international scoring system (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal function. Annals of Oncology [Internet]. 2012;23(3):722 - 729.